[
    [
        {
            "time": "2020-12-31",
            "original_text": "AstraZeneca, Merck, AbbVie Struck Biggest Licensing Deals in 2020",
            "features": {
                "keywords": [
                    "AstraZeneca",
                    "Merck",
                    "AbbVie",
                    "Licensing Deals"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "AstraZeneca, Merck, AbbVie Struck Biggest Licensing Deals in 2020",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "2021-04-28",
            "original_text": "Bristol-Myers Misses Q1 Profit As Pandemic Hits Cancer Drugs Sales",
            "features": {
                "keywords": [
                    "Bristol-Myers",
                    "Q1 Profit",
                    "Pandemic",
                    "Cancer Drugs Sales"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Bristol-Myers Misses Q1 Profit As Pandemic Hits Cancer Drugs Sales",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-05-10",
            "original_text": "2 Undervalued Pharmaceutical Stocks to Buy Now",
            "features": {
                "keywords": [
                    "Undervalued",
                    "Pharmaceutical Stocks",
                    "Buy Now"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "2 Undervalued Pharmaceutical Stocks to Buy Now",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        }
    ]
]